Viewing on a PDA? Click here to read this email.
Medical Progress Today
mpt home | sign up

Volume 7, Number 2
January 15, 2010


PRINTER FRIENDLY

In the Spotlight

The Blue Pill Or The Red Pill?
When it comes to meds, cheaper is not always better

Tomas Philipson, Forbes.com, 1-15-10

President Obama once famously quipped, "If there's a blue pill and a red pill, and the blue pill is half the price of the red pill and works just as well, why not pay half price for the thing that's going to make you well?" Increasing the use of cheaper, but still effective treatments, medicines and procedures is one of the central ideas behind a new science called comparative effectiveness research.
Continue reading . . .


News

· Medical Device Recalls and the FDA Approval Process, Zuckerman, D. M., Brown, P., Nissen, S. E., Archives of Internal Medicine, 6-14-11
· Patent Reform Gets Key Support in House, Julian Pecquet, The Hill, 6-14-11
· $4.3 Billion Pledged at Vaccine Fund-Raiser, Donald G. McNeil Jr., New York Times, 6-13-2011
· Physicians Leaving Practices for health System Employment, Karen Cheung, FierceHealthcare, 6-13-11

More Headlines >>


Commentary

· Marco Rubio takes on 'Medi-scare' Marc A. Thiessen, Washington Post, 6-13-11
· 'Vouchercare' Is the Right Name for Medicare Laurence Kotlikoff, Bloomberg, 6-15-11
· Built To Fail: Health Insurance Exchanges Under The Affordable Care Act
· Can Exchanges Help Consumers Get Good Value Insurance? Depends On Where You Live Sabrina Corlette, Kaiser Health News, 6-15-11
· The ObamaCare Bad News Continues Karl Rove, Wall Street Journal, 6-16-11
· ObamaCare's Economic Flaws Doug Holtz-Eakin, Investor's Business Daily, 6-8-11

More Commentary >>


Research

· Why States Are So Miffed about Medicaid Economics, Politics, and the "Woodwork Effect", Benjamin D. Sommers et al., New England Journal of Medicine, 6-15-11
· Auditing Access to Specialty Care for Children with Public Insurance, Joanna bisgaier et al., New England Journal of Medicine, 6-16-11
· Moving Beyond Fee-For-Service: The Case for Managed Care in Medicaid, Michael Ramlet and Carey Lafferty, American Action Forum, 6-14-11
· The New Gold Rush: Prospectors are Hoping to Mine Opportunities in the Healthcare Industry, Health Research Institute, PricewatershouseCoopers, 6-14-11
· Active Purchasing for Health Insurance Exchanges: An Analysis of Options, Sabrina Corlette and JoAnn Volk, RWJF, 6-14-11

More Research>>



Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

SPOTLIGHT

The Blue Pill Or The Red Pill?

INNOVATIVE IDEAS:
Podcast Series


Richard Amerling, MD, Director of Outpatient Dialysis at Beth Israel Medical Center in New York, Associate Professor of Clinical Medicine at Albert Einstein College of Medicine, and a Director of the Association of American Physicians and Surgeons, talks to Paul Howard, director of the Center for Medical Progress at the Manhattan Institute, about impending severe cuts in funding for dialysis due to take effect in January, 2011. Dr. Amerling says these cuts will lead to rationing of certain medicines used currently for these patients, and may force some dialysis units out of business.

Click here to listen to the podcast

 

Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org